FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385578004: Norelgestromin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459757011 Norelgestromin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479783019 Norelgestromin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
365671000195111 norelgestromina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
828611000172110 norelgestromine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Norelgestromin (substance) Is a Synthetic steroid false Inferred relationship Some
Norelgestromin (substance) Is a Progesterone false Inferred relationship Some
Norelgestromin (substance) Is a Synthetic progestogen (substance) true Inferred relationship Some
Norelgestromin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Norelgestromin (substance) Is a Steroid hormone true Inferred relationship Some
Norelgestromin (substance) Is a Norsteroid true Inferred relationship Some
Norelgestromin (substance) Is a Progestational hormone false Inferred relationship Some
Norelgestromin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some
Norelgestromin (substance) Is a Estrane true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Norelgestromin+ethinyl estradiol 6mg/0.75mg patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norelgestromin (substance) Inferred relationship Some
Product containing norelgestromin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 1
Ethinyl estradiol 600micrograms / norelgestromin 6mg transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norelgestromin (substance) Inferred relationship Some
Product containing ethinylestradiol and norelgestromin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 2
Ethinyl estradiol 600micrograms / norelgestromin 6mg transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norelgestromin (substance) Inferred relationship Some
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norelgestromin (substance) Inferred relationship Some
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 2
Ethinylestradiol and norelgestromin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 2
Norelgestromin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 1
Ethinylestradiol and norelgestromin only product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norelgestromin (substance) Inferred relationship Some 2
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Norelgestromin (substance) Inferred relationship Some 2
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Norelgestromin (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start